American Society of Cataract and Refractive Surgery Meeting

Combined treatment of cataract surgery with iStent or iStent inject trabecular bypass stent showed benefits to the ocular surface and overall improvement in ocular surface disease.

In this video perspective from the virtual American Society of Cataract and Refractive Surgery meeting, P. Dee G. Stephenson, MD, discusses a study she presented on the enVista toric MX60ET hydrophobic acrylic IOL from Bausch + Lomb..

Next year’s American Society of Cataract and Refractive Surgery meeting in San Francisco has been rescheduled from April to August, according to an ASCRS statement.

In this video perspective from the virtual American Society of Cataract and Refractive Surgery meeting, Steven M. Silverstein, MD, discusses the results of a phase 3 study of Dextenza for the treatment of allergic conjunctivitis.

John A. Hovanesian, MD, FACS, discusses visual results in patients implanted with the SC9 extended depth of focus IOL developed by CORD from the virtual American Society of Cataract and Refractive Surgery meeting.

Juan Carlos Izquierdo, MD, discusses a study he presented looking at ab interno canaloplasty combined with ECP in patients with previous failed trabeculectomy at the virtual American Society of Cataract and Refractive Surgery meeting.

Jason Bacharach, MD, discusses phase 1 study results he presented at the virtual American Society of Cataract and Refractive Surgery meeting about a travoprost hydrogel intracameral implant for the treatment of glaucoma.

Both IOP and medication use were reduced and glaucoma did not progress in the majority of patients in a study looking at 5-year visual field and OCT outcomes after iStent implantation in a real-world clinical setting.

High visualization, ease of use and greater pain reduction for up to 30 days after cataract surgery led to higher patient and physician ratings for Dextenza compared with placebo, according to a speaker.

An artificial intelligence algorithm designed for the autonomous diagnosis of keratoconus was able to correctly differentiate all patients with keratoconus from healthy subjects, according to a speaker at the virtual American Society of Cataract and Refractive Surgery meeting.